Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBR SystemsEBRCZ +5.41%18 Days Sales Outstanding is 58.95 as of Jun. 2026, which is 42% below its 10-year median of 102.03. GuruFocus rates EBRCZ with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 809 Medical Devices & Instruments companies, EBR Systems ranks better than 71.32% on this metric.
EBR Systems's average Accounts Receivable for the
three
months ended in Jun. 2026 was $1.70 Mil. EBR Systems's Revenue for the
three
months ended in Jun. 2026 was $2.64 Mil.
Hence, EBR Systems's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 58.95.
The historical rank and industry rank for EBR Systems's Days Sales Outstanding or its related term are showing as below:
EBRCZ'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.96 Med: 102.03 Max: 102.03
Current: 48.96
During the past 5 years, EBR Systems's highest Days Sales Outstanding was 102.03. The lowest was 48.96. And the median was 102.03.
EBRCZ's Days Sales Outstanding is ranked better than 71.32% of 809
companies
in the Medical Devices & Instruments industry
Industry Median: 64.94
vs EBRCZ: 48.96
EBR Systems's Days Sales Outstanding
declined
from Jun. 2025 (139.02) to Jun. 2026 (58.95).
EBR Systems (OTCPK:EBRCZ) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
EBR Systems Days Sales Outstanding Related Terms
EBR Systems Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for EBR Systems's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBRCZ vs INGN, OWLT, APYX: Days Sales Outstanding Comparison
For the Medical Devices subindustry, EBR Systems's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBR Systems Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EBR Systems's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where EBR Systems's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBR Systems (EBRCZ) has a Days Sales Outstanding of 58.95 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on EBR Systems and its competitors. This is 42% below median its historical median of 102.03. Over the past decade, EBR Systems' Days Sales Outstanding has ranged from 48.96 to 102.03. According to the industry distribution chart, EBR Systems ranks #232 out of 809 companies in the Medical Devices & Instruments industry, placing it in the top 28.7%.
Is EBR Systems' Days Sales Outstanding too high?
EBR Systems' current Days Sales Outstanding of 58.95 is 42% below median its 10-year median of 102.03. Over the past 10 years, this metric has ranged from a low of 48.96 to a high of 102.03. The Medical Devices & Instruments industry median Days Sales Outstanding is 64.94. EBR Systems' value of 58.95 is 9.2% below this industry median. Based on the distribution chart, EBR Systems ranks #232 out of 809 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EBR Systems has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does EBR Systems' Days Sales Outstanding compare to INGN and OWLT?
According to the Medical Devices & Instruments industry distribution chart, EBR Systems ranks #232 out of 809 companies for Days Sales Outstanding. This puts EBR Systems in the upper half of its industry. The industry median Days Sales Outstanding is 64.94. EBR Systems' value of 58.95 is 9.2% below this benchmark. Historically, EBR Systems' own Days Sales Outstanding has ranged from 48.96 to 102.03 over the past decade. While the company's 10-year median is 102.03 vs. the industry median of 64.94, EBR Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 64.94, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBR Systems's current Days Sales Outstanding of 58.95 is 9.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on EBR Systems and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 64.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBR Systems's current Days Sales Outstanding is 58.95, which is 42% below median its own 10-year median of 102.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBR Systems stock overvalued right now?
EBR Systems (EBRCZ) has a current Days Sales Outstanding of 58.95. The current Days Sales Outstanding is 58.95, which is 42% below median its 10-year median of 102.03 and 9.2% below the Medical Devices & Instruments industry median of 64.94. EBR Systems' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For EBR Systems (EBRCZ), the current Days Sales Outstanding is 58.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside the left ventricle of the heart. It conducts its operations in the United States.
18GF Score
Get the complete analysis for EBRCZ
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBRCZ has been successfully added to your 
